[ad_1]
Tola, A., Mishore, K. M., Ayele, Y., Mekuria, A. N. & Legese, N. Treatment outcome of tuberculosis and associated factors among TB-HIV Co-infected patients at public hospitals of Harar town, Eastern Ethiopia. A five-year retrospective study. BMC Public Health 19, 1–12 (2019).
Mugusi, F. M. et al. Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health 9, 1–8 (2009).
Gezae, K. E., Abebe, H. T., Gebretsadik, L. G. & Gebremeskel, A. K. Predictors of time to death among TB/HIV co-infected adults on ART at two governmental hospitals in Mekelle, Ethiopia, 2009–2016: A retrospective cohort study. Ann. Infect. Dis. Epidemiol. 2020(5), 1049 (2020).
Wondimu, W., Dube, L. & Kabeta, T. Factors affecting survival rates among adult TB/hiv co-infected patients in Mizan Tepi University teaching hospital, South West Ethiopia. HIV/AIDS (Auckland, NZ) 12, 157 (2020).
Kwan, C. K. & Ernst, J. D. HIV and tuberculosis: A deadly human syndemic. Clin. Microbiol. Rev. 24, 351–376 (2011).
Sileshi, B., Deyessa, N., Girma, B., Melese, M. & Suarez, P. Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: A retrospective cohort study. BMC Infect. Dis. 13, 1–10 (2013).
Deribew, A. et al. Common mental disorders in TB/HIV co-infected patients in Ethiopia. BMC Infect. Dis. 10, 1–8 (2010).
Deribew, A. et al. The synergy between TB and HIV co-infection on perceived stigma in Ethiopia. BMC Res. Notes. 3, 1–4 (2010).
J.U.N.P. on HIV/AIDS, Global AIDS Monitoring 2017: Indicators for monitoring the 2016 United Nations Political Declaration on HIV and AIDS. Geneva: Joint United Nations Programme on HIV, AIDS (2016).
W.H. Organization, Global tuberculosis report 2013, World Health Organization (2013).
Kassu, A. et al. Coinfection and clinical manifestations of tuberculosis in human immunodeficiency virus-infected and-uninfected adults at a teaching hospital, northwest Ethiopia. J. Microbiol. Immunol. Infect. 40, 116 (2007).
Demissie, M., Lindtjørn, B. & Tegbaru, B. Human immunodeficiency virus (HIV) infection in tuberculosis patients in Addis Ababa, Ethiop. J. Heal. Dev. 14 (2000).
Jacobs, G. B. & Ikomey, G. M. Biomedical research and capacity building: Bilateral collaboration between research institutes in South Africa and Cameroon. SAMJ S. Afr. Med. J. 106, 953 (2016).
W.H. Organization, Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: Recommendations for a public health approach, World Health Organization (2016).
Teklu, A. M. et al. Factors associated with mortality of TB/HIV co-infected patients in Ethiopia, Ethiop. J. Health Sci. 27, 29–38 (2017).
Mitku, A. A., Dessie, Z. G., Muluneh, E. K. & Workie, D. L. Prevalence and associated factors of TB/HIV co-infection among HIV Infected patients in Amhara region, Ethiopia. Afr. Health Sci. 16, 588–595 (2016).
Beyene, Y., Geresu, B. & Mulu, A. Mortality among tuberculosis patients under DOTS programme: A historical cohort study. BMC Public Health 16, 1–6 (2016).
Gesesew, H. et al. Predictors of mortality in a cohort of tuberculosis/HIV co-infected patients in Southwest Ethiopia. Infect. Dis. Poverty 5, 1–9 (2016).
Shaweno, D. & Worku, A. Tuberculosis treatment survival of HIV positive TB patients on directly observed treatment short-course in Southern Ethiopia: A retrospective cohort study. BMC Res. Notes 5, 1–8 (2012).
Refera, H. & Wencheko, E. Survival of HIV-TB co-infected adult patients under ART in Ambo Referral Hospital, Ethiopia. Ethiop. J. Heal. Dev. 27, 88–93 (2013).
Domingos, M. P., Caiaffa, W. T. & Colosimo, E. A. Mortality, TB/HIV co-infection, and treatment dropout: Predictors of tuberculosis prognosis in Recife, Pernambuco State, Brazil. Cad. Saude Publ. 24, 887–896 (2008).
Català, L. et al. Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment. Int. J. Tuberc. Lung Dis. 15, 263–269 (2011).
Mekonnen, D., Derbie, A. & Desalegn, E. TB/HIV co-infections and associated factors among patients on directly observed treatment short course in Northeastern Ethiopia: A 4 years retrospective study. BMC Res. Notes 8, 1–6 (2015).
Lelisho, M. E., Teshale, B. M., Tareke, S. A., Hassen, S. S., Andargie, S. A., Merera, A. M. & Awoke, S. Modeling survival time to death among TB and HIV co-infected adult patients: An institution-based retrospective cohort study. J. Racial Ethn. Heal. Disparities 1–13 (2022).
Zachariah, R. et al. Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi?. Int. J. Tuberc. Lung Dis. 11, 848–853 (2007).
Gesesew, H. A., Ward, P., Woldemichael, K. & Mwanri, L. Early mortality among children and adults in antiretroviral therapy programs in Southwest Ethiopia, 2003–15. PLoS ONE 13, e0198815 (2018).
Damtew, B., Mengistie, B. & Alemayehu, T. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan Afr. Med. J. 22 (2015).
Assemie, M. A., Muchie, K. F. & Ayele, T. A. Incidence and predictors of loss to follow up among HIV-infected adults at Pawi General Hospital, northwest Ethiopia: Competing risk regression model. BMC Res. Notes 11, 1–6 (2018).
Tachbele, E. & Ameni, G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: A six years retrospective cohort study. Epidemiol. Health 38 (2016).
Aung, Z. Z. et al. Survival rate and mortality risk factors among TB–HIV co-infected patients at an HIV-specialist hospital in Myanmar: A 12-year retrospective follow-up study. Int. J. Infect. Dis. 80, 10–15 (2019).
Tadele, A., Shumey, A. & Hiruy, N. Survival and predictors of mortality among adult patients on highly active antiretroviral therapy at debre-markos referral hospital, North West Ethiopia; A retrospective cohort study. J. AIDS Clin. Res. 5, 2 (2014).
Camara, A. et al. L’issue du traitement, la survie et ses facteurs de risque chez les nouveaux tuberculeux co-infectés par le VIH pendant l’épidémie d’Ebola à Conakry. Rev. Epidemiol. Sante Publique 65, 419–426 (2017).
Hailemariam, S., Tenkolu, G., Tadese, H. & Vata, P. K. Determinants of survival in HIV patients: A retrospective study of Dilla University Hospital HIV cohort. Int. J. Virol. AIDS 3, 23 (2016).
Haileamlak, A. et al. Predictors of hospitalization among children on ART in Ethiopia: A Cohort study, Ethiop. J. Health Sci. 27, 53–62 (2017).
Pardeshi, G. Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course (2009).
Mojumdar, K., Vajpayee, M., Chauhan, N. K. & Mendiratta, S. Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population. BMC Public Health 10, 1–8 (2010).
Xu, X. et al. Delays in care seeking, diagnosis and treatment among pulmonary tuberculosis patients in Shenzhen, China. Int. J. Tuberc. Lung Dis. 17, 615–620 (2013).
Raizada, N. et al. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India. PLoS ONE 4, e5999 (2009).
Tarekegn, S. The effect of HAART on incidence of tuberculosis among HIV infected patients in Hawassa University Referral Hospital, Addis Ababa Addis Abba Addis Abba Univ. (2011).
Nguyen, D. T., Jenkins, H. E. & Graviss, E. A. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients. PLoS ONE 13, e0196022 (2018).
Mageda, K., Leyna, G. H. & Mmbaga, E. J. High initial HIV/AIDS-Related mortality and-its predictors among patients on antiretroviral therapy in the kagera region of Tanzania: A five-year retrospective cohort study. AIDS Res. Treat. 2012 (2012).
Nansera, D. et al. Mortality and loss to follow-up among tuberculosis and HIV co-infected patients in rural southwestern Uganda. Int. J. Tuberc. Lung Dis. 16, 1371–1376 (2012).
Gezie, L. D. Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: Multilevel analysis. BMC Res. Notes 9, 1–9 (2016).
Maruza, M. et al. Survival of HIV-infected patients after starting tuberculosis treatment: A prospective cohort study. Int. J. Tuberc. Lung Dis. 16, 618–624 (2012).
Iliyasu, Z. & Babashani, M. Prevalence and predictors of tuberculosis coinfection among HIV-seropositive patients attending the Aminu Kano Teaching Hospital, Northern Nigeria. J. Epidemiol. 903030070 (2009).
Wondimeneh, Y., Muluye, D. & Belyhun, Y. Prevalence of pulmonary tuberculosis and immunological profile of HIV co-infected patients in Northwest Ethiopia. BMC Res. Notes 5, 1–6 (2012).
Temesgen, A., Gurmesa, A. & Getchew, Y. Joint modeling of longitudinal CD4 count and time-to-death of HIV/TB co-infected patients: A case of Jimma University Specialized Hospital. Ann. Data Sci. 5, 659–678 (2018).
Sinshaw, Y., Alemu, S., Fekadu, A. & Gizachew, M. Successful TB treatment outcome and its associated factors among TB/HIV co-infected patients attending Gondar University Referral Hospital, Northwest Ethiopia: an institution based cross-sectional study. BMC Infect. Dis. 17, 1–9 (2017).
Alene, K. A., Nega, A. & Taye, B. W. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect. Dis. 13, 1–9 (2013).
Rojo, P., Carpenter, D., Venter, F., Turkova, A. & Penazzato, M. The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV. J. Int. AIDS Soc. 23, e25576 (2020).
Harries, A. D., Zachariah, R. & Lawn, S. D. Providing HIV care for co-infected tuberculosis patients: A perspective from sub-Saharan Africa [State of the art series. Tuberculosis. Edited by ID Rusen. Number 3 in the series]. Int. J. Tuberc. Lung Dis. 13, 6–16 (2009) .
Vijay, S., Kumar, P., Chauhan, L. S., Narayan Rao, S. V. & Vaidyanathan, P. Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India. PLoS One 6, e21008 (2011).
Roshanaei, G., Ghannad, M. S., Poorolajal, J., Mohraz, M. & Molaeipoor, L. Survival rates among co-infected patients with human immunodeficiency virus/tuberculosis in Tehran, Iran. Iran. J. Public Health. 46, 1123 (2017).
Dyer, O. Covid-19: Many poor countries will see almost no vaccine next year, aid groups warn. BMJ Br. Med. J. 371 (2020).
Hasse, B. et al. Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study. Antimicrob. Agents Chemother. 58, 2363–2368 (2014).
[ad_2]
Source link